Morphotek(R), Inc. Announces FDA Acceptance of Investigational New Drug Application for MORAb-004, a Monoclonal Antibody for the Treatment of So... (ne of our collaborative partners said N...)

HOME >> MEDICINE >> NEWS

Morphotek(R), Inc. Announces FDA Acceptance of Investigational New Drug Application for MORAb-004, a Monoclonal Antibody for the Treatment of Solid Tumors

Date:6/9/2009

ne of our collaborative partners," said Nicholas Nicolaides, President and CEO of Morphotek. "Targeting of pericytes is a novel strategy in the anti-angiogenesis field and we look forward to reporting the results of these studies."

Morphotek obtained exclusive rights to develop and commercialize this antibody worldwide from the Ludwig Institute for Cancer Research (LICR). The endosialin protein as well as a precursor monoclonal antibody specific for endosialin, which is related to MORAb-004, were discovered in Dr. Lloyd Old's laboratory at LICR.

About Morphotek

Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, is a biopharmaceutical company specializing in the development of protein and antibody products through the use of novel and proprietary technologies. These technologies have been successfully applied to a variety of molecules that are suitable for pharmaceutical product development in the areas of antibody therapeutics, protein therapeutics, product manufacturing, drug target discovery, and improved output traits for commercial applications. The company is currently focusing its platform on the development and manufacturing of therapeutic antibodies for the treatment of cancer, inflammation and infectious disease. For more information, please visit www.morphotek.com.

About Eisai Corporation of North America

Eisai Corporation of North America is a wholly-owned subsidiary of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Eisai focuses its efforts in three therapeutic areas: neurology, gastrointestinal disorders and oncology/critical care. Eisai Corporation of North America supports the activities of its operating companies in North America, which include: Eisai Research Institute of Boston, Inc., a
'/>"/>

SOURCE Morphotek, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Morphotek(R), Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer
2. Abbott Announces New EAS(R) Myoplex(R) Strength Formula Nutrition Shake and Debuts Bottle Packaging
3. Life Spine Announces Appointment of Todd Fanning as Vice President of Sales
4. CareFusion Announces Board of Directors, Progress on Alaris Consent Decree
5. ThinIdentity(TM) Announces Two New Board Members
6. Brookdale Announces Completion of Follow-On Offering
7. Scientx Groupe, S.A. Announces Completion of Credit Facility and Incremental Capital Infusion
8. ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
9. Oxygen Biotherapeutics, Inc. Announces Private Placement Financing Agreement and Offer to Acquire Warrants
10. Microbridge Technologies Announces Micro-Flow Differential Pressure Sensors for Medical Respiration and Industrial HVAC Applications
11. DATATRAK Announces New Products and Features at DIA San Diego

Post Your Comments:

(Date:11/30/2009)..., Nov. 30 /PRNewswire-FirstCall/ - AIM Health Grou...lly integrated health care company, announced toda...nded September 30, 2009 (the "Quarter") increased ...8. At the same time EBITDA(1) increased 290% to $9...sis. The Company also announced that revenues incr...

(Date:11/30/2009)...LE, Nov. 30 Major League Basebal...nsas City Royals and recently acquired by the Chic...#174;). The award is given annually to a Major Lea..., courage and dedication of baseball great Fred Hu...28-year-old Redlands, Calif., native made his MLB ...

(Date:11/30/2009)...Nov. 30 I,m surprised and dismayed...k. At every step of my life and my career as an a...dent Ombudsman for the Texas Youth Commission, I h...My professional commitment to the protection, prev...my personal passion. ,, Of the many concerns ...

(Date:11/30/2009)...on dose was equivalent to 113 chest X-rays, study ...s) -- More than half of patients who have abdomina...maging tests that expose them to extra radiation, ...dominal and pelvic series were performed on 500 pa...ents were 30 to 50 years of age. The researchers c...

(Date:11/30/2009)...S ANGELES, Nov. 30 Menopause - it,...ngs with it a host of uncomfortable symptoms that ...or sleep, mood swings, weight gain , night sweats...ymptoms of menopause and perimenopause. What,s wor...ull ten years before actual menopause occurs (peri...

Breaking Medicine News(10 mins):Health News:AIM Health Group Inc. continues increased quarterly profits 2 Health News:AIM Health Group Inc. continues increased quarterly profits 3 Health News:AIM Health Group Inc. continues increased quarterly profits 4 Health News:Mark Teahen Named 2009 Hutch Award Winner 2 Health News:Independent Ombudsman for Texas Youth Commission Resigns 2 Health News:CT Scan Patients May Get Unnecessary Imaging 2 Health News:Anti-Aging Institute of California Offers New Natural Solution for Menopause Symptoms 2

[0] AIM Health Group Inc. continues increased quarterly profits [0] Mark Teahen Named 2009 Hutch Award Winner [0] Independent Ombudsman for Texas Youth Commission Resigns [0] CT Scan Patients May Get Unnecessary Imaging [2] Anti-Aging Institute of California Offers New Natural Solution for Menopause Symptoms

..., Ky., May 13 We,ve all made mistakes: bell botto...unscreen. All that,s in the past. Thanks to adva...know sun worshipping isn,t chic. In fact, it,s do...hs. Skin cancer is the most common form of cancer...

...LLS, N.J., May 13 ScienceFirst was recently recog...NJ) at its 46th Annual Awards Exhibition. , , Sci... bronze medal for her concept and design of a spea...cates of Excellence. One of the entries was the Sc...

... only oral antidiabetic fixed-dose combination med... metformin , , DEERFIELD, Ill. and OSAKA, Japan, ...its wholly-owned subsidiary, Takeda Pharmaceutical...cation ACTO plus met(R) (pioglitazone HCl and met...

... The ALS Association,s is launching...e, during Major League Baseball,s ,4ALS Awareness,...anniversary of Lou Gehrig,s famous ,Luckiest Man, ...e ALS Association,s is launching the ,Covering All...

... MessageSolution, Inc., the global ...tions for electronic discovery, litigation support...ces the release of MessageSolution Email & Fil...prise Suite with SharePoint Archiving is a central...

...N, May 13 President Barack Obama and Speaker Nan...a meeting on health care reform this morning at th...ce President Joe Biden, House Majority Leader Sten...the President,s remarks. , , "Good morning. T...

Other Medicine News:Health News:Get Sun Smart at the Spa 2 Health News:FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes 2 Health News:FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes 3 Health News:FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes 4 Health News:70th Anniversary of Lou Gehrig's Farewell Speech: The ALS Association Launches the 'Covering All the Bases Hitting Challenge' 2 Health News:70th Anniversary of Lou Gehrig's Farewell Speech: The ALS Association Launches the 'Covering All the Bases Hitting Challenge' 3 Health News:MessageSolution Releases Email & File Archive Enterprise Suite with SharePoint Archiving at Microsoft TechEd North America 2009 2 Health News:MessageSolution Releases Email & File Archive Enterprise Suite with SharePoint Archiving at Microsoft TechEd North America 2009 3 Health News:MessageSolution Releases Email & File Archive Enterprise Suite with SharePoint Archiving at Microsoft TechEd North America 2009 4 Health News:MessageSolution Releases Email & File Archive Enterprise Suite with SharePoint Archiving at Microsoft TechEd North America 2009 5 Health News:Pelosi: Health Care Legislation Will Be on the House Floor by the End of July 2

Get Sun Smart at the Spa ScienceFirst Receives ADCNJ Awards FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes 70th Anniversary of Lou Gehrig's Farewell Speech: The ALS Association Launches the 'Covering All the Bases Hitting Challenge'MessageSolution Releases Email & File Archive Enterprise Suite with SharePoint Archiving at Microsoft TechEd North America 2009 Pelosi: Health Care Legislation Will Be on the House Floor by the End of July

(Date:11/30/2009)...YORK, Nov. 30 Reportlinker.com ann...ble in its catalogue: ,, Diabetes Diagnostics ...eportlinker.com/p0164347/Diabetes-Diagnostics---A-...agnosis market is driven by a steady increase in t...in the developed and developing parts of the world...

(Date:11/30/2009)...Ill., Nov. 30 The Simmons law firm...ed to representing thousands of women that were se...ular birth control pill manufactured and marketed ...Panel on Multidistrict Litigation has ordered that...suits be consolidated and centralized for pretrial...

(Date:11/30/2009)...N, Italy, November 30 Health Robot...,s development plans and product specifications,fo...ted Parenteral,Nutrition", a new key component of ... at Las Vegas, ASHP (Booth # 114). , "I l... to the,TPNstation,s blueprints and to find out if...

[0] Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective [0] Simmons Firm's Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer [0] Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th

...ts to Risk Mitigation Strategies Consistent with ...RAZER, Pa., Sept. 15 Cephalon, Inc. (Nasdaq:,CEPH...etter from the Food,and Drug Administration (FDA) ...or FENTORA(R) (fentanyl buccal tablet) [C-II] as a...ancer breakthrough pain. In its letter,the FDA req...

...he American Society Of Clinical Psychopharmacology...Y HILLS, Mass., Sept. 15 Joseph F. Finn, Jr.,C.P....nc. ("Spherics") for,the benefit of creditors, ann...ual property will be sold at a sealed bid auction ...effects on cognitive functions at rates of,over 40...

Other Medicine Technology:Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain 2 Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain 3 Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain 4 Spherics, Inc. Announces Reduced Cognitive Impairment of Novel Extended Release Topiramate (SRx-502) as Compared to Topamax(R) 2

Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain Spherics, Inc. Announces Reduced Cognitive Impairment of Novel Extended Release Topiramate (SRx-502) as Compared to Topamax(R)

Fast-Cath Hemostasis Introducers

Bx Velocity Rx with Hepacoat

EPT-1000 XP Cardiac Ablation System

Irrigating Cannula Handpiece (Titanium)

Medicine Products:

Fast-Cath Hemostasis Introducers Bx Velocity Rx with Hepacoat EPT-1000 XP Cardiac Ablation System Irrigating Cannula Handpiece (Titanium)

Morphotek(R), Inc. Announces FDA Acceptance of Investigational New Drug Application for MORAb-004, a Monoclonal Antibody for the Treatment of So...(ne of our collaborative partners said N...),Health